Bell Investment Advisors, Inc Denali Therapeutics Inc. Transaction History
Bell Investment Advisors, Inc
- $574 Million
- Q2 2025
A detailed history of Bell Investment Advisors, Inc transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 123 shares of DNLI stock, worth $2,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
123
Previous 52
136.54%
Holding current value
$2,014
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DNLI
# of Institutions
251Shares Held
135MCall Options Held
148KPut Options Held
15.4K-
Black Rock Inc. New York, NY13.2MShares$216 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$193 Million0.0% of portfolio
-
Baillie Gifford & CO11.6MShares$190 Million0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.58MShares$108 Million0.01% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.26MShares$103 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.2B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...